Clinical Decision Support Tool for Parental Tobacco Treatment in Hospitalized Children

Brian P Jenssen1, Eric D Shelov2, Christopher P Bonafide2

  • 1Robert Wood Johnson Foundation Clinical Scholars Program, University of Pennsylvania, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania and The Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

A new clinical decision support (CDS) tool integrated into electronic health records (EHR) proved feasible and acceptable for pediatric residents to counsel parents on smoking cessation and reduce secondhand smoke (SHS) exposure in children.

Area of Science:

  • Pediatric Health
  • Clinical Informatics
  • Public Health

Background:

  • Secondhand smoke (SHS) exposure poses significant health risks to children.
  • Pediatricians play a crucial role in addressing parental smoking behaviors.
  • Integrating smoking cessation support into routine pediatric care is essential.

Purpose of the Study:

  • To develop and assess a clinical decision support (CDS) tool within the electronic health record (EHR).
  • To evaluate the feasibility, acceptability, and usability of the CDS tool for pediatric residents.
  • To aid pediatricians in providing smoking cessation counseling and treatment to parents of hospitalized children exposed to SHS.

Main Methods:

  • A mixed-methods study involving first-year pediatric residents on an inpatient unit.
  • Residents received training on smoking cessation, nicotine replacement therapy (NRT), and the CDS tool.
  • The CDS tool alerted for SHS exposure, facilitated problem list updates, referred to quitlines, and linked to NRT prescriptions.

Main Results:

  • The CDS tool was utilized for 49% of alerted patients, with 39% having SHS exposure added to the problem list.
  • 32% of parents were referred to a quitline, and 14% received NRT prescriptions.
  • The tool was rated as acceptable and usable by clinicians, with an average System Usability Scale score of 85.

Conclusions:

  • A non-interruptive CDS tool integrated into the EHR is feasible, acceptable, and usable for promoting smoking cessation counseling in pediatric settings.
  • The tool effectively supports pediatric residents in addressing SHS exposure among hospitalized children's families.
  • Further research is warranted to examine the impact of this CDS tool on patient outcomes.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
316
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.5K